MEDNAX, Inc. (MD - Free Report) , the country’s leading provider of newborn hearing screen services, recently launched the MEDNAX Audiology Institute for innovation and partnership across all aspects of pediatric hearing loss. This will cover early detection of hearing loss, diagnosis and treatment along with access to better care.
The parent company’s largest provider of maternal-fetal, newborn and pediatric subspecialty services, namely Pediatrix Medical Group, Inc., has the Pediatrix Newborn Hearing Screen Program, which allows screening of more than 850,000 newborns across 30 states as well as above 430 hospitals every year. This unique program has to date screened beyond seven million newborns across the nation, which is an impressive statistic.
MEDNAX’s 25 years of enriched experience of providing newborn hearing screens has enabled it to own a proper infrastructure, perfect for research, education, safe and secure initiatives. The company is well poised to delve into research and opportunities that would enhance every phase of care for children with hearing disabilities. It looks forward to tie up with leading and likeminded organizations for boosting the pediatric hearing loss care further.
The progress behind MEDNAX Audiology Institute was boosted by both the hearing screen success as well as the requirement for better and more comprehensive approach. Early detection and timely intervention with audiology assessment would help provide better treatment, which in turn, can improve the patients’ quality of life.
According to the American Academy of Otolaryngology, more than 3 million American children suffer hearing loss. Of this, nearly 1.3 million are aged below 3 years. The institute's research also shows that 90% of deaf children are born to parents with normal hearing ability.
However, technology has helped advancing the treatments for children's hearing needs over the past few years. And since demand for such treatment is on a high, it creates ample scope for MEDNAX to provide the best care to children.
Shares of this Zacks Rank #3 (Hold) have rallied 12.4% in a year’s time, underperforming its industry’s growth of 39.8%.
Stocks to Consider
Investors interested in the medical sector might take a look at some better-ranked stocks like WellCare Health Plans, Inc. (WCG - Free Report) , Molina Healthcare, Inc (MOH - Free Report) and Triple-S Management Corporation (GTS - Free Report) .
WellCare provides managed care services for government-sponsored health care programs. The company sports a Zacks Rank # 1 (Strong Buy) and managed to pull off an average four-quarter positive surprise of 53.89%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Molina provides Medicaid-related solutions to meet the health care needs of low-income families and individuals as well as assist state agencies in their administration of the Medicaid program across the United States. Sporting a Zacks Rank of 1, the stock delivered a skyrocketing average four-quarter beat of nearly 164.17% in three of the last four quarters.
Triple-S Management and its subsidiaries provide a portfolio of managed care and related products in the commercial, Medicare and Medicaid markets in Puerto Rico, the United States. It carries a Zacks Rank #2 (Buy) and managed to come up with a whopping average four-quarter earnings surprise of 187.91%.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>